Meta AnalysisID 5908
参苓白术散治疗溃疡性结肠炎：随机对照试验的Meta分析
CRD42018100477
To compare Shen-Ling-Bai-Zhu-San treatment with medicine treatment in treating patients of ulcerative colitis.
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Formula: 1Meta-analysis: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final meta_analysis record.
- Meta Analysis Id
- 5908
- Evidence Id
- 14466
- Core Evidence Id
- 14466
- Source Meta Analysis Id
- 5891
- Herb2 Meta Analysis Id
- HBMA005891
- Crd Id
- CRD42018100477
- Title
- Shen-Ling-Bai-Zhu-San for ulcerative colitis: a meta-analysis of randomized controlled trials
- Review Question
- To compare Shen-Ling-Bai-Zhu-San treatment with medicine treatment in treating patients of ulcerative colitis.
- Study Type Included
- Randomized controlled trials (RCTs) and clinical controlled trials (CCTs).
- Condition Being Studied
- Ulcerative colitis.
- Participant
- Randomized controlled trials (RCTs) and clinical controlled trials (CCTs).
- Animal
- Human Disease Modelled
- Intervention
- The trials comparing CShen-Ling-Bai-Zhu-San treatment (CMT treatment) with medicine treatment (MT treatment, including sulphasalazine, and 5-Aminosalicylic acid), and comparing Chinese herbal medicine treatment (CT treatment) with medicine treatment (MT treatment) were included. If the patients in the two groups were given the same therapies, such as acupuncture, steroids or immunosuppressives treatment, the trials were also included.
- Comparator Control
- Sulphasalazine, and 5-Aminosalicylic acid.
- Main Outcome
- Response rate (RR1) Secondary outcome(s) Relapse rate (RR2) and adverse events (AE), quality of life(QOL).
- Outcome Measure
- Additional Outcome
- Relapse rate (RR2) and adverse events (AE), quality of life(QOL).
- Study Method
- Meta-analysis, Systematic review
- Keyword
- Colitis, Ulcerative; Drugs, Chinese Herbal; Humans; Randomized Controlled Trials as Topic; Remission Induction; shen ling bai zhu
- Contact
- Long Yang [email protected]
- Organisational Affiliation
- Xi'an Hospital of traditional Chinese Medicine
- Funding Source
- Other Selection Criteria
- Final Publication
- Same Topic Review
- Published Protocol
- Review Type
- Language
- English
- Country
- China
- Review Stage
- Review Ongoing
- First Submission Date
- 2018-06-15
- Registration Date
- 2018-07-17
- Anticipated Start Date
- 2018-08-01
- Anticipated Completion Date
- 2018-11-01
- Title Cn
- 参苓白术散治疗溃疡性结肠炎：随机对照试验的Meta分析
- Title En
- Shen-Ling-Bai-Zhu-San for ulcerative colitis: a meta-analysis of randomized controlled trials
- Bilingual Status
- complete